Xanthic Biopharma is Other Pharmaceuticals and Biotechnology in Canada that focus on drink powders business. Founded in 1968. They cover business area such as manufacturer, cannabis, product, inconvenience, messiness, stigma, Marijuana, non-combustible cannabi, customer, nausea, vomiting, chemotherapy, appetite, people, HIV/AIDS, chronic pain and muscle spasm.
Other Pharmaceuticals and Biotechnology
1968
( 56 years old in 2024 )
Drink Powders
-
2100 Bloor Street West
Suite 6339
Torronto, Ontario M6S 5A5
Canada
Private
manufacturercannabisproductinconveniencemessinessstigmaMarijuananon-combustible cannabicustomernauseavomitingchemotherapyappetitepeopleHIV/AIDSchronic pain and muscle spasm
* We use standard office opening hours in near Xanthic Biopharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Xanthic Biopharma is Other Pharmaceuticals and Biotechnology business from Canada that founded in 1968 (56 years old in 2024), Xanthic Biopharma business is focusing on Drink Powders.
Xanthic Biopharma headquarter office and corporate office address is located in 2100 Bloor Street West Suite 6339 Torronto, Ontario M6S 5A5 Canada.
Xanthic Biopharma was founded in Canada.
In 2024, Xanthic Biopharma is currently focus on drink powders sector.
Above is snippet of Google Trends for "drink powders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Xanthic Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
